Trial NCT01259297

View at ClinicalTrials.gov 
Org. Study IDs: CSPP100G2301
Secondary IDs: 2009-010170-38

Last trial update was posted on 2014-04-08

MeSH Interventions

Aliskiren Amlodipine Hydrochlorothiazide

MeSH Conditions


Other Conditions

Cardiovascular Events

Stopping Reasons

Terminated early in agreement with Health Authorities for feasibility reasons

Limitations And Caveats

Due to early termination, 1759 patients were randomized as against 11,000. Only 25 primary endpoints had accrued during median follow-up of 209 days as against planned 2000 in 5 years. These low numbers significantly limit interpretation of results.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID